TITLE

Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion

AUTHOR(S)
Singh, Vijay P.; Bhagat, Lakshmi; Navina, Sarah; Sharif, Rifat; Dawra, Rajinder K; Saluja, Ashok K.
PUB. DATE
July 2007
SOURCE
Gut;Jul2007, Vol. 56 Issue 7, p958
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Protease-activated receptor-2 (PAR-2) is present in the pancreas, where it has been shown to play a protective role during pancreatitis. However, the mechanism by which it protects against pancreatitis still remains to be elucidated. Acute pancreatitis is associated with premature zymogen activation and a blockage in digestive enzyme secretion. Aim: To examine the effects of PAR-2 activation on the severity of pancreatitis, and to determine whether its protective effects are mediated by affecting either premature activation or secretory blockage, or both. Results: The results confirmed that PAR-2 -/- mice have more severe pancreatitis than wild-type mice. Interestingly, intrapancreatic trypsin levels in the PAR-2 knockouts remained high after 6 h of pancreatitis, whereas they reverted to normal in the wild types. During pancreatitis, PAR-2 mRNA levels were upregulated in wild-type mice in response to supramaximal caerulein administration. Further, after a single injection of supramaximal caerulein, PAR-2 mRNA levels were also elevated, reaching a peak at 3 h. Stimulating PAR-2 with trypsin or the PAR-2-activating peptide, serine-leucine-isaleucine-glycine-arginine-leucine (SLIGRL), induced significantly more secretion from the acini of these caerulein-sensitised mice compared with the controls. PAR-2 activation also reversed the inhibition of secretion observed in both the caerulein and arginine models. Conclusions: Trypsin released during the early stages of pancreatitis activates PAR-2 receptors on the acinar cells and stimulates secretion from these cells. Thus, PAR-2 activation may decrease pancreatic injury and limit the severity of pancreatitis by allowing extracellular trypsin to act as a secretagogue.
ACCESSION #
25602403

 

Related Articles

  • Practice Guidelines in Acute Pancreatitis. Banks, Peter A.; Freeman, Martin L. // American Journal of Gastroenterology;Oct2006, Vol. 101 Issue 10, p2379 

    The article focuses on the guidelines for diagnosing and treating acute pancreatitis. There are three important phases of pathophysiology of acute pancreatitis. The first phase consists of premature activation of trypsin within pancreatic acinar cells. In the second phase, there is...

  • Cellular Alchemy.  // Diabetes Forecast;Dec2008, Vol. 61 Issue 12, p22 

    The article offers information on the research conducted regarding the conversion of non-insulin-making adult cells into insulin producers in mice in the U.S. It mentions that scientists were able to reprogram pancreatic exocrine cells by infecting them with viruses that were loaded with three...

  • The true culprit within the SPINK1 p.N34S-containing haplotype is still at large. Jian-Min Chen; Férec, Claude // Gut;Apr2009, Vol. 58 Issue 4, p478 

    In this article, the authors discuss the serine protease inhibitor Kazal-type 1(SPINK1), commonly known as pancreatic secretory trypsin inhibitor (PSTI). They note that PSTI was considered as one of the defensive mechanisms against a prematurely activate trypsin-driven digestive zymogen...

  • Antagonistic effect of TNF-alpha and insulin on uncoupling protein 2 (UCP-2) expression and vascular damage. Gómez-Hernández, Almudena; Perdomo, Liliana; de las Heras, Natalia; Beneit, Nuria; Escribano, Óscar; Otero, Yolanda F.; Guillßn, Carlos; Díaz-Castroverde, Sabela; Gozalbo-López, Beatriz; Cachofeiro, Victoria; Lahera, Vicente; Benito, Manuel // Cardiovascular Diabetology;2014, Vol. 13 Issue 1, p1 

    Background It has been reported that increased expression of UCP-2 in the vasculature may prevent the development of atherosclerosis in patients with increased production of reactive oxygen species, as in the diabetes, obesity or hypertension. Thus, a greater understanding in the modulation of...

  • Oscillations in oxygen tension and insulin release of individual pancreatic ob/ob mouse islets. Ortsäter, H.; Liss, P.; Lund, P. E.; Åkerman, K. E. O.; Bergsten, P. // Diabetologia;Oct2000, Vol. 43 Issue 10, p1313 

    Aims/hypothesis. The role of beta-cell metabolism for generation of oscillatory insulin release was investigated by simultaneous measurements of oxygen tension (pO2) and insulin release from individual islets of Langerhans.¶Methods. Individual islets isolated from the ob/ob-mice were...

  • Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice.  // Diabetology & Metabolic Syndrome;2012, Vol. 4 Issue 1, p32 

    The article presents a study on the rapid onset of adipose tissue hypertrophy, hepatosteatosis, and hyperinsulimia by ingestion of diet high in sucrose and fat. It mentions that after feeding mice, there were notably elevated plasma resistin levels. The result of the study shows that the rapid...

  • Exploring pathway interactions in insulin resistant mouse liver.  // BMC Systems Biology;2011, Vol. 5 Issue 1, p127 

    The article focuses on a study which aims at investigating interactions between biological pathways in phenotypes like insulin resistance. In the study, a method is designed to analyze the response to glucose intake on liver samples of normal, obese and insulin resistant mice. It discusses the...

  • Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes. Ahrén, Bo // Diabetes;Mar2015, Vol. 64 Issue 3, p715 

    The article presents a commentary on the effect of the incretin hormone GLP-1 on hepatic glucose production. It highlights the ability of the incretin to stimulate insulin secretion and inhibit glucagon secretion. Also discussed is the enhancement of glucose levels when the β-cells where...

  • The Pathogenesis of Pancreatic Pseudocysts--A Canine Experimental Model. Salinas, Alberto; Triebling, Andrew; Toth, Lewis; Dreiling, David A. // American Journal of Gastroenterology;Feb1985, Vol. 80 Issue 2, p126 

    In summary, an experimental model that mimics the pseudocyst formation in man was produced in dogs. The following conditions were met: 1) encapsulated cyst containing pancreatic juice: 2) an actively secreting pancreas with hyperamylasemia and pancreatitis; 3) a ductal communication: and 4) more...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics